Physician profile
Charles G Stahlmann
NPI 1558667071
$263,338.54
in general payments reported to CMS, 2019-2025
13 companies · $126K in 2025
The $126K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.50 · 2021: $91.16 · 2022: $5,348 · 2023: $37K · 2024: $95K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $217K · Travel and Lodging: $30K · Food and Beverage: $7,974 · Education: $3,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $216,515.00 |
| Travel and Lodging | $30,343.34 |
| Food and Beverage | $7,974.09 |
| Education | $3,017.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $258,346.60 | 2021-2025 | Breztri, Fasenra, Tezspire |
| Intuitive Surgical, INC. | $3,779.16 | 2023 | Ion, Da Vinci Surgical System |
| Inari Medical, INC. | $335.21 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $322.11 | 2022-2025 | Trelegy Ellipta |
| Abiomed | $126.51 | 2023 | Impella |
| Baxter Healthcare | $123.58 | 2024 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $118.55 | 2023 | Tyvaso |
| Mylan Specialty L.P. | $57.88 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $48.22 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.17 | 2019-2025 | |
| La Jolla Pharmaceutical Company | $21.58 | 2021 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Advanced Respiratory, INC | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Stahlmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.